Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that ...

We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands among Wednesday’s ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

The state government has received investment intents worth Rs 4,349 crore in the pharmaceutical and biotechnology sector ...

New study shows move is also hindering the country's efforts to become self-sufficient in production of the grain ...

If the 118th Congress does not reauthorize the farm bill, it will be incumbent upon the 119 th Congress to pass an updated ...

The need to harness and tap into numerous benefits of Genetically Modified Organisms (GMOS) has become paramount in the prevailing food insecurity being witness in the country. However, the battle for ...

Researchers from the Manchester Institute of Biotechnology and the Department of Chemistry at The University of Manchester ...

A new study highlighting the importance of a large protein complex called the exocyst in cell growth, division and communication reveals new functions and mechanisms that are essential to how ...

Technology has become a crucial part of the modern world. Technical fields including biotechnology and information technology play a major role in shaping the future workforce. Nowadays, courses like ...

Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...

Hippocrates, the “father of modern medicine,” is credited with the admonition ... Experts at the North Carolina Biotechnology Center were impressed by the platform, and helped bootstrap the growth of ...